Mindzilla – Coronavirus

Coronavirus

Vital Tool to Study Virus Evolution in the Test Tube

June 10, 2021
Mindzilla

Brisbane, Australia — Variants of viruses, such as that causing COVID-19, can now be quickly studied in the laboratory, even before they emerge in nature and become a major public health challenge. The...

Coronavirus Testing Made Quick and Easy

May 27, 2021
Mindzilla

Thuwal, Saudi Arabia — A new rapid coronavirus test developed by KAUST scientists can deliver highly accurate results in less than 15 minutes. The diagnostic, which brings together electrochemical...

SARS-CoV-2 RNA Discovery Unlocks New Potential Treatments

May 27, 2021
Mindzilla

Oxford, UK — An international and multidisciplinary team led by researchers at the University of Oxford, University of Glasgow, and University of Heidelberg, has uncovered the interactions that SARS-CoV-2...

COVID-Fighter’s Guide to T cells

May 26, 2021
Mindzilla

La Jolla, CA — In a new paper, scientists from La Jolla Institute for Immunology (LJI) bring together research findings from COVID-19 researchers around the world. The results are striking: human T...

Antibodies that Enhance SARS-CoV-2 Infection — A Possible Factor for Severe COVID-19

May 25, 2021
Mindzilla

Osaka, Japan — A research group from Osaka University led by Professor Hisashi Arase and consisting of researchers from the Research Institute for Microbial Diseases, the Institute for Protein Research,...

Novel Defense Mechanism for SARS-CoV-2 Discovered

May 24, 2021
Mindzilla

Sapporo, Japan — Scientists from Hokkaido University have discovered a novel defensive response to SARS-CoV-2 that involves the viral pattern recognition receptor RIG-I. Upregulating expression of...

Modelling can Predict Mutation “Hotspots” and Antibody Escapers in SARS-CoV-2 Spike Protein

May 21, 2021
Mindzilla

New York, NY — SARS-CoV-2 has evolved to acquire mutations on the spike protein–the part of the virus that protrudes from its surface and latches onto cells to infect them–that enhance...

New Testing Platform for COVID-19 is an Efficient and Accurate Alternative to Gold-Standard RT-qPCR Tests

May 19, 2021
Mindzilla

Philadelphia, PA — Throughout the COVID-19 pandemic, supply chain shortages of reagents and test kits have limited the rapid expansion of clinical testing needed to contain the virus. Investigators...

The Triple Threat of Coronavirus

May 14, 2021
Mindzilla

London, UK — Severe symptoms of COVID-19, leading often to death, are thought to result from the patient’s own acute immune response rather than from damage inflicted directly by the virus. Immense...

Comprehensive Map of the SARS-CoV-2 Genome

May 13, 2021
Mindzilla

Cambridge, MA — In early 2020, a few months after the Covid-19 pandemic began, scientists were able to sequence the full genome of the virus that causes the infection, SARS-CoV-2. While many of its...

Novel Coronavirus’ Spike Protein Plays Additional Key Role in Illness

May 4, 2021
Mindzilla

La Jolla, CA — Scientists have known for a while that SARS-CoV-2’s distinctive “spike” proteins help the virus infect its host by latching on to healthy cells. Now, a major new study...

How SARS-CoV-2 Hijacks Human Cells to Evade Immune System

April 30, 2021
Mindzilla

La Jolla, CA — Researchers at University of California San Diego School of Medicine have discovered one way in which SARS-CoV-2, the coronavirus that causes COVID-19, hijacks human cell machinery to...

SARS-CoV-2 Curtails Immune Response in the Gut

April 27, 2021
Mindzilla

Cambridge, UK — In an effort to determine the potential for COVID-19 to begin in a person’s gut, and to better understand how human cells respond to SARS-CoV-2, the scientists used human intestinal...

Nanobodies Inhibit SARS-CoV-2 Infection

April 27, 2021
Mindzilla

Parkville, Australia — Australian researchers have identified neutralising nanobodies that block the SARS-CoV-2 virus from entering cells in preclinical models. The discovery paves the way for further...

Among COVID-19 Survivors, an Increased Risk of Death, Serious Illness

April 23, 2021
Mindzilla

St. Louis, MO — As the COVID-19 pandemic has progressed, it has become clear that many survivors — even those who had mild cases — continue to manage a variety of health problems long after...

SARS-CoV-2: Infection Induces antibodies capable of killing infected cells

April 21, 2021
Mindzilla

Paris, France — Drawing on epidemiological field studies and the French COVID hospital cohort coordinated by Inserm, teams from the Institut Pasteur, the CNRS and the Vaccine Research Institute (VRI,...

Gut’s Immune Response in COVID-19 may not Provide Efficient Protection of Other Organs

April 20, 2021
Mindzilla

Erlangen, Germany — Our guts may not provide long-lasting systemic immunity from COVID-19, which is where immune cells circulate through the body to provide protection to other organs, finds a new...

Virologists Develop Broadly Protective Coronavirus Vaccines

April 19, 2021
Mindzilla

Blacksburg, VA — A candidate vaccine that could provide protection against the COVID-19 virus and other coronaviruses has shown promising results in early animal testing. The candidate coronavirus...

COVID-19: Scientists Identify Human Genes that Fight Infection

April 19, 2021
Mindzilla

La Jolla, CA — Scientists at Sanford Burnham Prebys have identified a set of human genes that fight SARS-CoV-2 infection, the virus that causes COVID-19. Knowing which genes help control viral infection...

Simulations Reveal How Dominant SARS-CoV-2 Strain Binds to Host, Succumbs to Antibodies

April 19, 2021
Mindzilla

Los Alamos, NM — Large-scale supercomputer simulations at the atomic level show that the dominant G form variant of the COVID-19-causing virus is more infectious partly because of its greater ability...

T&C

Privacy